2024 ICD-10-CM Diagnosis Code D46.9

Myelodysplastic syndrome, unspecified

ICD-10-CM Code:
D46.9
ICD-10 Code for:
Myelodysplastic syndrome, unspecified
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Neoplasms
    (C00–D49)
    • Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
      (D37-D48)
      • Myelodysplastic syndromes
        (D46)

D46.9 is a billable diagnosis code used to specify a medical diagnosis of myelodysplastic syndrome, unspecified. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Unspecified diagnosis codes like D46.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • 46,XY disorder of sex development
  • Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent
  • Acute myeloid leukemia and myelodysplastic syndrome related to radiation
  • Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
  • Childhood myelodysplastic syndrome
  • Congenital hypoplasia of adrenal gland
  • Hematologic complication of procedure
  • Hematologic complication of procedure
  • MIRAGE syndrome
  • Myelodysplastic syndrome
  • Neoplastic complication of procedure
  • Neoplastic complication of procedure
  • Short stature co-occurrent and due to endocrine disorder
  • Therapy related acute myeloid leukemia and myelodysplastic syndrome
  • Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent
  • Therapy-related myelodysplastic syndrome
  • Therapy-related myelodysplastic syndrome
  • Therapy-related myelodysplastic syndrome
  • Therapy-related myelodysplastic syndrome
  • Therapy-related myelodysplastic syndrome

Clinical Classification

Clinical Information

  • Myelodysplastic Syndromes

    clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. they predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into acute myeloid leukemia.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Myelodysplasia NOS

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert D46.9 to ICD-9-CM

  • ICD-9-CM Code: 238.75 - Myelodysplastic synd NOS
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education


Myelodysplastic Syndromes

Your bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting. If you have a myelodysplastic syndrome, the stem cells do not mature into healthy blood cells. Many of them die in the bone marrow. This means that you do not have enough healthy cells, which can lead to infection, anemia, or easy bleeding.

Myelodysplastic syndromes often do not cause early symptoms and are sometimes found during a routine blood test. If you have symptoms, they may include:

  • Shortness of breath
  • Weakness or feeling tired
  • Skin that is paler than usual
  • Easy bruising or bleeding
  • Pinpoint spots under the skin caused by bleeding
  • Fever or frequent infections

Myelodysplastic syndromes are rare. People at higher risk are over 60, have had chemotherapy or radiation therapy, or have been exposed to certain chemicals. Treatment options include transfusions, drug therapy, chemotherapy, and blood or bone marrow stem cell transplants.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Myelodysplastic Syndromes Treatment (PDQ®)

Learn about the different types of myelodysplastic syndromes and their risk factors, signs and symptoms, tests to diagnose, factors affecting prognosis, and treatment.
[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.